First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody as First-line Treatment for Patients with Non-Squamous Non-Small Cell Lung Cancer Sep 11, 2018 Life Science
Tianjin Tasly Out-licenses US Rights to TCM Angina Drug in $50 Million Deal Sep 11, 2018 Life Science
Miracor Medical closes final tranche of Series-D, bringing the round to €30M Sep 5, 2018 Life Science
China Parenting Network Holdings Limited (CPN) Supports Maternal and Infant Ecosystem by Technology Strength, and Invests in Multiple Areas Sep 5, 2018 Life Science
Resverlogix Presents at Clinical Trials in Alzheimer’s Disease (CTAD) Asia 2018 Sep 4, 2018 Life Science
